Cargando…
Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.)
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Endocrine Society
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816497/ https://www.ncbi.nlm.nih.gov/pubmed/36353808 http://dx.doi.org/10.3803/EnM.2022.601 |
| _version_ | 1784864545976614912 |
|---|---|
| author | Park, Hyunju Chung, Jae Hoon |
| author_facet | Park, Hyunju Chung, Jae Hoon |
| author_sort | Park, Hyunju |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9816497 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Korean Endocrine Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98164972023-01-11 Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) Park, Hyunju Chung, Jae Hoon Endocrinol Metab (Seoul) Response Korean Endocrine Society 2022-12 2022-11-10 /pmc/articles/PMC9816497/ /pubmed/36353808 http://dx.doi.org/10.3803/EnM.2022.601 Text en Copyright © 2022 Korean Endocrine Society https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Response Park, Hyunju Chung, Jae Hoon Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title | Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title_full | Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title_fullStr | Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title_full_unstemmed | Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title_short | Frequency of TERT Promoter Mutations in Real-World Analysis of 2,092 Thyroid Carcinoma Patients (Endocrinol Metab 2022;37:652-63, Heera Yang et al.) |
| title_sort | frequency of tert promoter mutations in real-world analysis of 2,092 thyroid carcinoma patients (endocrinol metab 2022;37:652-63, heera yang et al.) |
| topic | Response |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816497/ https://www.ncbi.nlm.nih.gov/pubmed/36353808 http://dx.doi.org/10.3803/EnM.2022.601 |
| work_keys_str_mv | AT parkhyunju frequencyoftertpromotermutationsinrealworldanalysisof2092thyroidcarcinomapatientsendocrinolmetab20223765263heerayangetal AT chungjaehoon frequencyoftertpromotermutationsinrealworldanalysisof2092thyroidcarcinomapatientsendocrinolmetab20223765263heerayangetal |